These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14664761)

  • 1. Metronomic therapy for breast cancer.
    Kaur H; Budd GT
    Curr Oncol Rep; 2004 Jan; 6(1):49-52. PubMed ID: 14664761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
    Kamat AA; Kim TJ; Landen CN; Lu C; Han LY; Lin YG; Merritt WM; Thaker PH; Gershenson DM; Bischoff FZ; Heymach JV; Jaffe RB; Coleman RL; Sood AK
    Cancer Res; 2007 Jan; 67(1):281-8. PubMed ID: 17210709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metronomic chemotherapy in 2011: update and perspectives].
    Benbrahim Z; Massard C; El Mesbahi O
    Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic chemotherapy: an antiangiogenic scheduling.
    Laquente B; Viñals F; Germà JR
    Clin Transl Oncol; 2007 Feb; 9(2):93-8. PubMed ID: 17329220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic scheduling of lower dose cancer chemotherapy.
    Gately S; Kerbel R
    Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic dosing of chemotherapy: applications in pediatric oncology.
    Stempak D; Seely D; Baruchel S
    Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer.
    Gille J; Spieth K; Kaufmann R
    J Dtsch Dermatol Ges; 2005 Jan; 3(1):26-32. PubMed ID: 16353746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
    Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
    Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.
    Bocci G; Nicolaou KC; Kerbel RS
    Cancer Res; 2002 Dec; 62(23):6938-43. PubMed ID: 12460910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic properties of metronomic chemotherapy in breast cancer.
    Tonini G; Schiavon G; Silletta M; Vincenzi B; Santini D
    Future Oncol; 2007 Apr; 3(2):183-90. PubMed ID: 17381418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
    Kerbel RS; Shaked Y
    Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic chemotherapy for advanced breast cancer patients.
    Cazzaniga ME; Dionisio MR; Riva F
    Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
    Samuel DP; Wen PY; Kieran MW
    Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player.
    Benelli R; Monteghirfo S; Balbi C; Barboro P; Ferrari N
    Int J Cancer; 2009 Jun; 124(12):2989-96. PubMed ID: 19319982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.
    Kieran MW; Turner CD; Rubin JB; Chi SN; Zimmerman MA; Chordas C; Klement G; Laforme A; Gordon A; Thomas A; Neuberg D; Browder T; Folkman J
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):573-81. PubMed ID: 16282886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic scheduling: the future of chemotherapy?
    Gasparini G
    Lancet Oncol; 2001 Dec; 2(12):733-40. PubMed ID: 11902515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.